
    
      To evaluate and compare Pharmacokinetics/Pharmacodynamics, safety and tolerability of
      monolayer combination of Gemigliptin/Rosuvastatin 50/20mg in comparison to bilayer
      combination of Gemigliprin/Rosuvastatin 50/20mg administered in healthy volunteers
    
  